The Morrison Government is continuing its strong support for women and girls with endometriosis, investing more than $9.5 million in five innovative research projects.
The projects will lead to improved diagnosis and treatment of endometriosis and a better understanding of its causes. They include creating an evidence base for clinical care, comparing treatment options to improve quality of life, and identifying early risk factors for endometriosis.
Endometriosis is a common yet frequently under-recognised chronic disease. It affects one in every ten Australian women and girls, with the average diagnosis taking between seven to ten years.
It is a highly individualised disease, with its symptoms and impact ranging significantly from person to person. It often leads to severe chronic pain and in some cases, compromised fertility and sexual function.
The Government’s investment comes from its landmark Medical Research Future Fund’s Emerging Priorities and Consumer Driven Research Initiative.
Funding will go to five leading research institutions: Deakin University, Monash University, Murdoch Children’s Research Institute, The University of Melbourne and The University of Queensland.
The Government is profoundly committed to tackling this often misunderstood and crippling condition. Two years ago, we launched the National Action Plan for Endometriosis – Australia’s first ever blueprint seeking to improve the treatment, understanding and awareness of the disease. Our ultimate aim is to find a cure.
These research projects will contribute to a greater understanding of endometriosis for the benefit of women and their loved ones across Australia and the global community.
Further information on the MRFF is available at www.health.gov.au/mrff.
Successful applicants for the research funding include:
Administering institution |
Project |
Total grant value (GST exclusive) |
Deakin University |
A randomised controlled trial comparing yoga, cognitive behaviour therapy and education to improve quality of life and reduce health care costs in endometriosis. |
$893,981.25 |
Monash University |
Creating an evidence base for clinical care: A randomised controlled study examining the efficacy of the low FODMAP diet for the relief of gastrointestinal symptoms in endometriosis. |
$948,619.20 |
Murdoch Children’s Research Institute |
Long STEPPP-A: Longitudinal study of teenagers with endometriosis, period and pelvic pain in Australia to identify early risk factors, educational and management strategies that will lead to optimal health outcomes and appropriate health utilisation. |
$1,963,118.00 |
University of Melbourne |
Improving diagnosis and treatment of endometriosis. |
$3,929,233.50 |
The University of Queensland |
Genetic variants, early life exposures, and longitudinal endometriosis symptoms study (GELLES). |
$1,856,540.00 |
Total |
$9,591,491.95 |